Arbor Biosciences and LGC, Biosearch Technologies Partner on Marker Discovery and Genotyping in Agrigenomics

Arbor Biosciences, a division of Chiral Technologies, Inc. and worldwide leader in next generation sequencing (NGS) target enrichment, today announced a partnership with Biosearch Technologies, the complete genomics portfolio of LGC Group. LGC Group was founded over 175 years ago, and today supplies products and services in the life sciences sector to improve human healthcare, agri- food technology, and the environment across the world.

Written byArbor Biosciences and LGC Biosearch Technologies
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Together, the organizations will use their extensive resources for genetic testing and marker discovery to deliver custom sequencing solutions to the agrigenomics market.

Through the partnership, Biosearch Technologies will become the exclusive global provider of custom hybridization-based targeted sequencing oligonucleotide panels powered by myBaits technology to commercial agricultural organizations and seed breeding companies. Arbor Biosciences will maintain their strong presence in academic and government research laboratories by continuing to serve these researchers with catalog and custom panels. Overall, the partnership will allow Biosearch Technologies to leverage their established relationships with commercial organizations by delivering a complimentary technology necessary for marker discovery in crop sciences.

Alison Devault, Director of Genomics at Arbor Biosciences stated “Custom hybridization capture kits for targeted NGS have been our speciality for almost a decade, and perfectly complement LGC Biosearch’s robust expertise with genotyping assays for commercial ag- bio applications. We are truly excited for this partnership ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies